Abstract
Since noting an apparent increase in hypocalcemia in neonates receiving gentamicin every 24 h (q 24 h) for ≥ 4 days, we have prospectively monitored serum calcium (Ca) values in these patients receiving prolonged gentamicin therapy. This study is a retrospective analysis of those values measured during gentamicin treatment. The study included neonates with gestational age ≥ 35 weeks who received ≥ 4 days of gentamicin therapy and in whom at least one serum Ca value was measured ≥ 47 h after initiation of therapy. Hypocalcemia was defined as a serum Ca level < 8 mg/dl (2 mmol/l). Data were analyzed by Student t-test, chi-square test, and Pearson product moment correlation. There were 1,624 neonates that met the study criteria. Ca was < 8 mg/dl in 241 (15%). Ca < 8 mg/dl was more likely in boys than in girls (16.4% vs 11.8%, P = 0.01) and in neonates < 37 weeks gestational age (GA) than in those ≥ 37 weeks GA (23.9% vs 14.1%, P = 0.01). A second Ca value was obtained in 883 neonates (54%); 23.2% of neonates with initial Ca < 8 mg/dl remained hypocalcemic, and 30% of these were receiving oral Ca supplementation. The second Ca value was < 8 mg/dl in eight neonates in whom initial Ca was ≥ 8 mg/dl. Hypocalcemia is not uncommon in neonates receiving gentamicin therapy, and it may occur more frequently in boys and late-preterm infants. These data suggest that the monitoring of serum Ca levels should be considered when gentamicin is given ≥ 4 days.
Similar content being viewed by others
References
Miron D (2001) Once daily dosing of gentamicin in infants and children. Pediatr Infect Dis J 20:1169–1173
Rao SC, Ahmed M, Hagan R (2006) One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates (review). Cochrane Database Syst Rev:CD006091
Agarwal G, Rastogi A, Pyati S, Wilks A, Pildes RS (2002) Comparison of once-daily versus twice-daily gentamicin dosing regimens in infants > or = 2500 g. J Perinatol 22:268–274
Moore RD, Lietman PS, Smith CR (1987) Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to MIC. J Infect Dis 155:93–99
Jackson GL, Sendelbach DM, Stehel EK, Baum MG, Manning MD, Engle WD (2003) Association of hypocalcemia with a change in gentamicin administration in term and near-term neonates. Pediatr Nephrol 18:653–656
Andronikou SK, Giapros VI, Cholevas VI, Papadopoulou ZL (1996) Effect of aminoglycoside therapy on renal function in full term infants. Pediatr Nephrol 10:766–768
Giapros VI, Andronikou SK (2003) Renal function and effect of aminoglycoside therapy during the first ten days of life. Pediatr Nephrol 10:46–52
Giapros VI, Cholevas VI, Andronikou SK (2004) Acute effects of gentamicin on urinary electrolyte excretion in neonates. Pediatr Nephrol 19:322–325
Parsons PP, Garland HO, Harpur ES, Old S (1997) Acute gentamicin-induced hypercalciuria and hypermagnesiuria in the rat: dose-response relationship and role of renal tubular injury. Br J Pharmacol 122:570–576
Zaloga GP, Chernow B, Pock A, Wood B, Zaritsky A, Zucker A (1984) Hypomagnesemia is a common complication of aminoglycoside therapy. Surg Gynecol Obstet 158:561–564
Hsu SC, Levine MA (2004) Perinatal calcium metabolism: physiology and pathophysiology. Semin Neonatol 9:23–36
Hoitsma AJ, Wetzels JF, Koene RA (1991) Drug-induced nephrotoxicity: aetiology, clinical features and management. Drug Saf 6:131–147
Elliott W, Patchin D (1992) Aminoglycoside-mediated calciuresis. J Pharmacol Exp Ther 262:151–156
Parsons PP, Garland HO, Harpur ES (2000) Localization of the nephron site of gentamicin-induced hypercalciuria in the rat: a micropuncture study. Br J Pharmacol 130:441–449
Brown EM, MacLeod RJ (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81:239–297
McLarnon SJ (2002) Aminoglycoside antibiotics induce pH-sensitive activation of the calcium-sensing receptor. Biochem Biophys Res Commun 29:771–777
Prada JA (2004) Calcium-regulating hormones. In: Polin RA, Fox WW, Abman S (eds) Fetal and neonatal physiology, 3rd edn. Saunders, Philadelphia, pp 303–314
Quarles LD (2003) Extracellular calcium-sensing receptors in the parathyroid gland, kidney, and other tissues. Curr Opin Nephrol Hypertens 12:349–355
Portale AA (1999) Blood calcium phosphorus and magnesium. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 4th edn. Lippincott, Williams, and Wilkins, Philadelphia, pp 115–118
Greer RF (2005) Disorders of calcium homeostasis. In: Spitzer AR (ed) Intensive care of the fetus and neonate, 2nd edn. Mosby, Philadelphia, pp 1179–1203
Chevalier RL (1996) Developmental renal physiology of the low birth weight preterm newborn. J Urol 156:714–719
Nielsen HC, Today JS (1985) Sex differences in avian embryo pulmonary surfactant production: evidence for sex chromosome involvement. Endocrinology 117:31–37
Nielsen HC (1992) Testosterone regulation of sex differences in fetal lung development. Proc Soc Exp Biol Med 199:446–452
Brion L, Fleishman A, Schwartz G (1991) Gentamicin interval in newborn infants as determined by renal function and post-conceptional age. Pediatr Nephrol 5:675–678
Tugay S, Bircan Z, Çağlayan C, Arısoy AE, Gökalp AS (2006) Acute effects of gentamicin on glomerular and tubular functions in preterm neonates. Pediatr Nephrol 21:1389–1392
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chiruvolu, A., Engle, W.D., Sendelbach, D. et al. Serum calcium values in term and late-preterm neonates receiving gentamicin. Pediatr Nephrol 23, 569–574 (2008). https://doi.org/10.1007/s00467-007-0707-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-007-0707-8